Steven Posnack | September 30, 2022
On October 6, 2022, we reach the end of the more than two-year glide path laid out for the information blocking regulations. Moving forward, expect to see periodic, experience-driven regulatory updates as well as continued work on education, outreach, and oversight, including the establishment of disincentives for health care providers. There may also be the possibility of information blocking advisory opinions if Congress grants the Secretary such authority.
Read Full Post.
Steven Posnack | May 24, 2022
While the federal government’s budget planning processes may have a certain mystique to them, some interesting tidbits are always in federal agency budgets if you know where to look. Fear not, because this blog post highlights a new legislative proposal associated with information blocking that’s been put forward by the Biden-Harris Administration for HHS. Specifically, the Administration has requested that Congress provide HHS with the authority to issue binding “advisory opinions” for the information blocking regulations as part of our implementation of the 21st Century Cures Act (Cures Act).
Read Full Post.
Rachel Nelson | February 28, 2022
The 21st Century Cures Act (Cures Act), signed into law by President Obama in 2016, directed ONC to implement a standardized process for the public to report claims of possible information blocking. The information blocking claims reporting process welcomes claims of possible information blocking from anyone who believes they may have experienced or observed information blocking. Any information received by ONC in connection with a claim or suggestion of possible information blocking and that could reasonably be expected to facilitate identification of the source of the information (claimant) is protected from disclosure under the Cures Act.
Read Full Post.
Kathryn Marchesini | December 20, 2021
Micky Tripathi | September 16, 2021
The ONC Cures Act Final Rule went into effect on April 5, 2021 and as a result we have seen an increase in both the quantity and complexity of questions regarding the regulations. We’re eager to help the industry successfully implement these new requirements and, even more important, to reap the many benefits it offers for patients, providers, health insurers, developers, and the possibilities it opens up for public health, population health, research – really,
Read Full Post.
